AustraliaBreaking News

Anteris Technologies (ASX:AVR) treats first US patients in PARADIGM trial, marking a major milestone for its DurAVR heart valve.

AGL Energy (ASX:AGL) narrowed its FY26 earnings guidance to $2.06B–$2.18B and boosts profit outlook.

Decidr AI Industries (ASX:DAI) secured $15 million through a heavily supported share placement.

Road safety technology provider Acusensus (ASX:ACE) reaffirmed its FY26 financial guidance.

President Donald Trump said he would pause a US-led effort to help stranded ships exit the Strait of Hormuz to see if an agreement with Iran to end the war could be finalized. Bloomberg's Derek Wallbank breaks down the developments.

Atlas Arteria (ASX:ALX) issued a formal recommendation for securityholders to reject an unsolicited, off-market takeover bid from IFM.

Aurizon Holdings (ASX:AZJ) has reaffirmed its full-year 2026 earnings guidance amid weather-related disruptions.

JB Hi-Fi (ASX:JBH) CEO Nick Wells has issued a cautionary outlook for the final quarter of the financial year.

Metallium (ASX:MTM) secured binding supply contracts for 50% of its Stage 1 United States e-waste feedstock target.

Emerald Resources (ASX:EMR) received the final regulatory works approval for its Dingo Range Gold Project.

Noxopharm (ASX:NOX) announced the engagement of Novotech to spearhead its US regulatory strategy.

Duratec (ASX:DUR) has been awarded a $68 million subcontract for the Darwin Ship Lift Facility.